Work

Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors

Year: 2015

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-015-0220-z

Authors: Sarah A. Holstein, James C. Bigelow, Richard D. Olson, Robert E. Vestal, Gerald M. Walsh, Raymond J. Hohl

Institutions: Roswell Park Comprehensive Cancer Center, Idaho State University, Gem Pharmaceuticals (United States), Penn State Cancer Institute

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2040192775

FWCI: 0.968

Cites: 34

Cited by: 8

Related to: 10